超氧化物
线粒体
活性氧
再灌注损伤
线粒体ROS
缺血
药理学
琥珀酸脱氢酶
化学
氧化应激
细胞生物学
生物
生物化学
医学
内科学
酶
作者
Annabel Sorby-Adams,Tracy A. Prime,Jan Lj. Miljković,Hiran A. Prag,Thomas Krieg,Michael P. Murphy,Michael P. Murphy
标识
DOI:10.1016/j.redox.2024.103161
摘要
Ischaemia-reperfusion (IR) injury is the paradoxical consequence of the rapid restoration of blood flow to an ischaemic organ. Although reperfusion is essential for tissue survival in conditions such as myocardial infarction and stroke, the excessive production of mitochondrial reactive oxygen species (ROS) upon reperfusion initiates the oxidative damage that underlies IR injury, by causing cell death and inflammation. This ROS production is caused by an accumulation of the mitochondrial metabolite succinate during ischaemia, followed by its rapid oxidation upon reperfusion by succinate dehydrogenase (SDH), driving superoxide production at complex I by reverse electron transport. Inhibitors of SDH, such as malonate, show therapeutic potential by decreasing succinate oxidation and superoxide production upon reperfusion. To better understand the mechanism of mitochondrial ROS production upon reperfusion and to assess potential therapies, we set up an in vitro model of IR injury. For this, isolated mitochondria were incubated anoxically with succinate to mimic ischaemia and then rapidly reoxygenated to replicate reperfusion, driving a burst of ROS formation. Using this system, we assess the factors that contribute to the magnitude of mitochondrial ROS production in heart, brain, and kidney mitochondria, as well as screening for inhibitors of succinate oxidation with therapeutic potential.
科研通智能强力驱动
Strongly Powered by AbleSci AI